Jaysynth Orgochem Limited (BOM:524592)
India · Delayed Price · Currency is INR 12.82
+0.31 (2.48%)
At close: Jun 15, 2026
Jaysynth Orgochem Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,597 | 2,280 | 2,118 | 1,931 | 14.62 | |
Revenue Growth (YoY) | 13.88% | 7.67% | 9.68% | 13106.64% | 18.67% |
Cost of Revenue | 1,773 | 1,522 | 1,489 | 1,399 | 14 |
Gross Profit | 823.44 | 758.48 | 628.71 | 531.51 | 0.62 |
Selling, General & Admin | 252.61 | 230.85 | 197.47 | 258.23 | 2.19 |
Other Operating Expenses | 350.69 | 299.72 | 253.44 | 232.79 | 1.6 |
Operating Expenses | 630.15 | 558.07 | 478.06 | 519.93 | 10.81 |
Operating Income | 193.29 | 200.41 | 150.65 | 11.58 | -10.19 |
Interest Expense | -16.72 | -16.26 | -3.28 | -3.08 | -2.69 |
Interest & Investment Income | - | 15.3 | 13.05 | 8.82 | 1.44 |
Earnings From Equity Investments | - | - | - | -0.16 | - |
Currency Exchange Gain (Loss) | - | 4.24 | 4.86 | 0.51 | - |
Other Non Operating Income (Expenses) | 30.37 | -2.64 | -1.43 | 1.65 | -0.01 |
EBT Excluding Unusual Items | 206.94 | 201.06 | 163.85 | 19.31 | -11.45 |
Gain (Loss) on Sale of Investments | - | 14.32 | 0.86 | 2.23 | - |
Gain (Loss) on Sale of Assets | - | -1.79 | -0.11 | 0.99 | - |
Other Unusual Items | - | - | 6.85 | 11.24 | - |
Pretax Income | 206.94 | 213.6 | 172.85 | 33.77 | -11.45 |
Income Tax Expense | 60.36 | 57.41 | 49.96 | 26.07 | 0 |
Net Income | 146.58 | 156.19 | 122.9 | 7.7 | -11.45 |
Net Income to Common | 146.58 | 156.19 | 122.9 | 7.7 | -11.45 |
Net Income Growth | -6.15% | 27.09% | 1495.44% | - | - |
Shares Outstanding (Basic) | 134 | 135 | 135 | 135 | 13 |
Shares Outstanding (Diluted) | 134 | 135 | 135 | 135 | 13 |
Shares Change (YoY) | -0.32% | - | - | 918.16% | - |
EPS (Basic) | 1.09 | 1.16 | 0.91 | 0.06 | -0.86 |
EPS (Diluted) | 1.09 | 1.16 | 0.91 | 0.06 | -0.86 |
EPS Growth | -5.85% | 27.09% | 1495.44% | - | - |
Free Cash Flow | -140.85 | 35.96 | 35.65 | 142.55 | -4.22 |
Free Cash Flow Per Share | -1.05 | 0.27 | 0.26 | 1.06 | -0.32 |
Dividend Per Share | 0.050 | 0.050 | 0.050 | - | - |
Gross Margin | 31.71% | 33.26% | 29.69% | 27.53% | 4.24% |
Operating Margin | 7.44% | 8.79% | 7.11% | 0.60% | -69.71% |
Profit Margin | 5.64% | 6.85% | 5.80% | 0.40% | -78.33% |
Free Cash Flow Margin | -5.42% | 1.58% | 1.68% | 7.38% | -28.87% |
EBITDA | 220.14 | 221.83 | 175.18 | 37.98 | -3.17 |
EBITDA Margin | 8.48% | 9.73% | 8.27% | 1.97% | -21.65% |
D&A For EBITDA | 26.85 | 21.42 | 24.53 | 26.4 | 7.03 |
EBIT | 193.29 | 200.41 | 150.65 | 11.58 | -10.19 |
EBIT Margin | 7.44% | 8.79% | 7.11% | 0.60% | -69.71% |
Effective Tax Rate | 29.17% | 26.88% | 28.90% | 77.19% | - |
Revenue as Reported | 2,627 | 2,315 | 2,139 | 1,947 | 17.36 |
Advertising Expenses | - | 13.35 | 7.76 | 13.01 | 0.22 |